chf

EMQN integrates Trinean’s DropSense™ into its standards QC procedures and quality assessment schemes for Molecular Genetic Labs

on 16/02/2016 14:16

Mainstay Medical full year 2015 preliminary results and business update

on 16/02/2016 14:15

Nexstim announces the result of its private placement

on 17/12/2015 11:04

Additional data confirm positive results for Clinical Trial of ReActiv8®

on 04/12/2015 10:24
Additional data confirm clinically important, statistically significant, and lasting improvement in pain, disability, and quality of life for people with Chronic Low Back Pain and limited treatment options
Read more

Nexstim Plc announces completion of enrolment of Phase III Clinical Trial in Stroke Therapy

on 03/12/2015 10:27
Recruitment completed ahead of schedule
Read more